Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin and the NO-system in T2D Nephropathy
NCT01208701Phase 2Completed
- Start
- May 2010
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in nephropathy, cardiovascular disease (CVD). Started May 2010; status: completed.
02
Drugs
atorvastatin
03
Conditions
nephropathycardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT01208701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01208701.